{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:59:44Z","timestamp":1790272784248,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.aohep.2026.102189","type":"journal-article","created":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T15:46:50Z","timestamp":1768751210000},"page":"102189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Overcoming barriers to HCV screening in Latin America: From evidence to action"],"prefix":"10.1016","volume":"31","author":[{"given":"Javier","family":"Crespo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Calleja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3321-0683","authenticated-orcid":false,"given":"Ezequiel","family":"Ridruejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0934-2202","authenticated-orcid":false,"given":"Marta","family":"Alonso-Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Cabezas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela Elia","family":"Castro-Narro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelia","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Cheinquer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie","family":"Perell\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Mendizabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2480-417X","authenticated-orcid":false,"given":"Fernando","family":"Cairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rio","family":"Guimar\u00e3es Pess\u00f4a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Emerim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Guerra Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Soza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6268-5444","authenticated-orcid":false,"given":"Leyla Maria","family":"Nazal Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar A.","family":"Beltran-Galvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Hern\u00e1ndez-Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Garz\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Coste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianela","family":"Alvarado Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1150-5197","authenticated-orcid":false,"given":"Mirtha","family":"Infante-Vel\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Carrera Estupi\u00f1\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisabel","family":"Valdez de Cuellar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Miguel","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Antonio","family":"Velarde-Ruiz Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Mayorga Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Antonio","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Adames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Girala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Garavito-Renter\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kriss","family":"Rodr\u00edguez Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Rodr\u00edguez-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Galloso Gentille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Dagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Mainardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10407","key":"10.1016\/j.aohep.2026.102189_bib0001","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(23)01320-X","article-title":"Hepatitis C","volume":"402","author":"Martinello","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.aohep.2026.102189_bib0002","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2188\/jea.JE20240034","article-title":"Causal Mediation Analyses for the Natural Course of Hepatitis C: A Prospective Cohort Study","volume":"35","author":"Huang","year":"2025","journal-title":"J Epidemiol"},{"issue":"4","key":"10.1016\/j.aohep.2026.102189_bib0003","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jmii.2022.04.011","article-title":"Improvement of patient-reported outcomes in patients achieving sustained virologic response with direct-acting antivirals for hepatitis C virus infection","volume":"55","author":"Yi","year":"2022","journal-title":"J Microbiol Immunol Infect"},{"issue":"2","key":"10.1016\/j.aohep.2026.102189_bib0004","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hep.22375","article-title":"Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression","volume":"48","author":"Thein","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.aohep.2026.102189_bib0005","first-page":"1","article-title":"Establishing a sustainable training program for laparoscopy in resource-limited settings: Experience in ghana","volume":"86","author":"Kang","year":"2020","journal-title":"Ann Glob Health"},{"issue":"3","key":"10.1016\/j.aohep.2026.102189_bib0006","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-0038-1666841","article-title":"The micro-elimination approach to eliminating hepatitis C: strategic and operational considerations","volume":"38","author":"Lazarus","year":"2018","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10.1016\/j.aohep.2026.102189_bib0007","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jiph.2022.11.021","article-title":"Modeling HCV elimination recovery following the COVID-19 pandemic in the United States: pathways to regain progress","volume":"16","author":"Blach","year":"2023","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.aohep.2026.102189_bib0008","article-title":"OP-9 Assessing the Burden and Budget Impacts of HCV Elimination Strategies in Uruguay Using Decision-Analytic Modeling","volume":"29","author":"Mainardi","year":"2024","journal-title":"Ann Hepatol"},{"issue":"7","key":"10.1016\/j.aohep.2026.102189_bib0009","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S2468-1253(25)00069-X","article-title":"A 2024 global report on national policy, programmes, and progress towards hepatitis B elimination: findings from 33 hepatitis elimination profiles","volume":"10","author":"Hiebert-Suwondo","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2026.102189_bib0010","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C: Final update of the series","volume":"73","year":"2020","journal-title":"J Hepatol."},{"issue":"1","key":"10.1016\/j.aohep.2026.102189_bib0011","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/jvh.13758","article-title":"Implementation of a re-linkage to care strategy in patients with chronic hepatitis C who were lost to follow-up in Latin America","volume":"30","author":"Mendizabal","year":"2023","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.aohep.2026.102189_bib0012","unstructured":"Global HIV Hepatitis and STIs Programmes, Health Product Policy and Standards. Global hepatitis report 2024: action for access in low- and middle-income countries. World Health Organization ed."},{"issue":"9","key":"10.1016\/j.aohep.2026.102189_bib0013","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.gastrohep.2019.09.002","article-title":"Elimination of hepatitis C. positioning document of the spanish association for the study of the liver (AEEH)","volume":"42","author":"Crespo","year":"2019","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2026.102189_bib0014","unstructured":"Global HIV Hepatitis and STIs Programmes. Updated Recommendations on Simplified Service Delivery And Diagnostics For Hepatitis C Infection. World Health Organization."},{"issue":"4","key":"10.1016\/j.aohep.2026.102189_bib0015","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/jvh.13238","article-title":"Epidemiology of hepatitis C virus infection in a country with universal access to direct-acting antiviral agents: data for designing a cost-effective elimination policy in Spain","volume":"27","author":"Crespo","year":"2020","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.aohep.2026.102189_bib0016","unstructured":"Xunta de Galicia. Estrategia para la eliminaci\u00f3n de la hepatitis C como problema de salud p\u00fablica en Galicia. https:\/\/www.sergas.es\/Saude-publica\/Documents\/6927\/Estrategia_eliminacion_hepatitis_C_en%20Galicia_cast.pdf?utm_source=chatgpt.com"},{"key":"10.1016\/j.aohep.2026.102189_bib0017","series-title":"REVIRAL: roadmap for the elimination of viral hepatitis in Latin America 13","author":"Crespo","year":"2025"},{"issue":"14","key":"10.1016\/j.aohep.2026.102189_bib0018","doi-asserted-by":"crossref","first-page":"E422","DOI":"10.1503\/cmaj.171154","article-title":"Consolidated principles for screening based on a systematic review and consensus process","volume":"190","author":"Dobrow","year":"2018","journal-title":"CMAJ"},{"issue":"4","key":"10.1016\/j.aohep.2026.102189_bib0019","first-page":"281","article-title":"Principles and practice of mass screening for disease]","volume":"65","author":"Wilson","year":"1968","journal-title":"Bol Oficina Sanit Panam"},{"issue":"4","key":"10.1016\/j.aohep.2026.102189_bib0020","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2471\/BLT.07.050112","article-title":"Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years","volume":"86","author":"Andermann","year":"2008","journal-title":"Bull World Health Organ."},{"issue":"2","key":"10.1016\/j.aohep.2026.102189_bib0021","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s41669-023-00458-3","article-title":"The efficiency of increased HCV testing and treatment strategies in Spain to achieve elimination goals","volume":"8","author":"Calleja","year":"2024","journal-title":"Pharmacoecon Open"},{"key":"10.1016\/j.aohep.2026.102189_bib0022","series-title":"Global Health Sector Strategy on Viral Hepatitis 2016\u20132021","year":"2016"},{"key":"10.1016\/j.aohep.2026.102189_bib0023","unstructured":"World Health Organization. Hepatitis C [Internet]. Geneva: World Health Organization; [cited 2026 Feb 5]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c"},{"key":"10.1016\/j.aohep.2026.102189_bib0024","unstructured":"Health Resources in Action; Global Hepatitis Alliance. Global State of Hepatitis Report 2024 [Internet]. Boston (MA): Health Resources in Action; 2024 [cited 2026 Feb 5]. Available from: https:\/\/hri.global\/wp-content\/uploads\/2024\/10\/HRI-GSHR-2024_Full-Report_Final.pdf."},{"issue":"1","key":"10.1016\/j.aohep.2026.102189_bib0025","doi-asserted-by":"crossref","first-page":"22275","DOI":"10.1038\/s41598-020-78970-3","article-title":"Infectious and non-infectious diseases burden among Haitian immigrants in Chile: a cross-sectional study","volume":"10","author":"Fuster","year":"2020","journal-title":"Sci Rep"},{"issue":"5 Suppl 1","key":"10.1016\/j.aohep.2026.102189_bib0026","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: incidence and risk factors","volume":"127","author":"Fattovich","year":"2004","journal-title":"Gastroenterology"},{"issue":"10179","key":"10.1016\/j.aohep.2026.102189_bib0027","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(18)32111-1","article-title":"Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study","volume":"393","author":"Carrat","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.aohep.2026.102189_bib0028","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciad319","article-title":"Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection","author":"Bhattacharya","year":"2023","journal-title":"Clin Infect Dis."},{"issue":"12","key":"10.1016\/j.aohep.2026.102189_bib0029","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1002\/jmv.26383","article-title":"Decompensated cirrhosis and liver transplantation negatively impact in DAA treatment response: real-world experience from HCV-LALREAN cohort","volume":"92","author":"Ridruejo","year":"2020","journal-title":"J Med Virol"},{"issue":"7","key":"10.1016\/j.aohep.2026.102189_bib0030","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/infdis\/jiv423","article-title":"Dried blood spots: a tool to ensure broad access to Hepatitis C screening, diagnosis, and treatment monitoring","volume":"213","author":"Soulier","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.aohep.2026.102189_bib0031","year":"2021"},{"issue":"10","key":"10.1016\/j.aohep.2026.102189_bib0032","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1111\/add.15456","article-title":"Cost-effectiveness of hepatitis C virus (HCV) elimination strategies among people who inject drugs (PWID) in Tijuana, Mexico","volume":"116","author":"Marquez","year":"2021","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.aohep.2026.102189_bib0033","doi-asserted-by":"crossref","DOI":"10.5539\/gjhs.v14n11p26","article-title":"Early Treatment of Hepatitis C Virus Improves Health Outcomes and Yields Cost-Savings: A Modeling Study in Argentina","volume":"14","author":"Elgart","year":"2022","journal-title":"Glob J Health Sci"},{"issue":"10","key":"10.1016\/j.aohep.2026.102189_bib0034","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/jama.2020.1123","article-title":"Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement","volume":"323","author":"Owens","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.aohep.2026.102189_bib0035","unstructured":"Centers for Disease Control and Prevention. Clinical screening and diagnosis for hepatitis C [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; [cited 2026 Feb 5]. Available from: https:\/\/www.cdc.gov\/hepatitis-c\/hcp\/diagnosis-testing\/index.html?utm_source=chatgpt.com"},{"issue":"7","key":"10.1016\/j.aohep.2026.102189_bib0036","first-page":"565","article-title":"Strategy for the Elimination of Hepatitis C in Cantabria","volume":"112","author":"Crespo","year":"2020","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.aohep.2026.102189_bib0037","series-title":"Ley para el cernimiento y diagn\u00f3stico de la hepatitis A, B y C en Puerto Rico","year":"2023"},{"key":"10.1016\/j.aohep.2026.102189_bib0038","unstructured":"Pan American Health Organization. Hepatitis B and C in the Americas: 2023 update. 2023. Available from: https:\/\/www.paho.org\/en\/news\/28-7-2023-increased-use-diagnostics-and-medicines-viral-hepatitis-could-save-100000-lives"},{"key":"10.1016\/j.aohep.2026.102189_bib0039","unstructured":"Pan American Health Organization. Guidelines for the response to tuberculosis, HIV, STIs, and viral hepatitis in persons deprived of liberty in Latin America and the Caribbean. 2024. Available from: https:\/\/www.paho.org\/en\/documents\/guidelines-response-tuberculosis-hiv-stis-and-viral-hepatitis-persons-deprived-liberty"},{"key":"10.1016\/j.aohep.2026.102189_bib0040","unstructured":"Pan American Health Organization. Japan becomes first official donor of Pan-American Highway for Digital Health Initiative. 2024. Available from: https:\/\/www.paho.org\/en\/news\/10-3-2024-japan-becomes-first-official-donor-pan-american-highway-digital-health-initiative"},{"key":"10.1016\/j.aohep.2026.102189_bib0041","unstructured":"Pan American Health Organization. Latin American countries aim to eliminate infectious diseases in prisons. 2025. Available from: https:\/\/www.paho.org\/en\/news\/14-2-2025-latin-american-countries-aim-eliminate-infectious-diseases-prisons"},{"key":"10.1016\/j.aohep.2026.102189_bib0042","unstructured":"Pan American Health Organization. 174th Session of the Executive Committee. Access to and use of high-cost medicines and technologies. 2024. Available from: https:\/\/iris.paho.org\/server\/api\/core\/bitstreams\/419afc4a-2038-4f86-9b3d-5277dc102468\/content"},{"key":"10.1016\/j.aohep.2026.102189_bib0043","unstructured":"Pan American Health Organization. Strategic Fund: Overview and Product Lists. 2024. Available from: https:\/\/www.paho.org\/en\/paho-strategic-fund"},{"issue":"3","key":"10.1016\/j.aohep.2026.102189_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2025.102662","article-title":"Economic evaluation of mass screening as a strategy for hepatitis C virus elimination in South Korea","volume":"18","author":"Choi","year":"2025","journal-title":"J Infect Public Health."},{"key":"10.1016\/j.aohep.2026.102189_bib0045","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.puhe.2024.01.012","article-title":"Universal screening and treatment towards the elimination of chronic hepatitis C in China: an economic evaluation","volume":"228","author":"Fang","year":"2024","journal-title":"Public Health"},{"issue":"1","key":"10.1016\/j.aohep.2026.102189_bib0046","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1186\/s12889-025-23809-7","article-title":"A scoping review on HCV screening strategies: population to screen and the test types","volume":"25","author":"Abrahim","year":"2025","journal-title":"BMC Public Health"},{"issue":"6","key":"10.1016\/j.aohep.2026.102189_bib0047","doi-asserted-by":"crossref","first-page":"ofaf302","DOI":"10.1093\/ofid\/ofaf302","article-title":"Simplified and Integrated Hepatitis C Virus Testing and Treatment Algorithm for Unhoused People Who Inject Drugs","volume":"12","author":"Ramers","year":"2025","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.aohep.2026.102189_bib0048","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2017.08.030","article-title":"HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma","volume":"68","author":"Ioannou","year":"2018","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.aohep.2026.102189_bib0049","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.cgh.2020.02.044","article-title":"Disease Progression in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antiviral Agents","volume":"18","author":"Mendizabal","year":"2020","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"1","key":"10.1016\/j.aohep.2026.102189_bib0050","first-page":"3","article-title":"Extrahepatic manifestations of chronic hepatitis C virus infection","volume":"3","author":"Cacoub","year":"2016","journal-title":"Ther Adv Infect Dis."},{"issue":"1","key":"10.1016\/j.aohep.2026.102189_bib0051","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jhep.2016.02.042","article-title":"Sofosbuvir\/velpatasvir improves patient-reported outcomes in HCV patients: Results from ASTRAL-1 placebo-controlled trial","volume":"65","author":"Younossi","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2026.102189_bib0052","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-074001","article-title":"Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study","volume":"382","author":"Hamill","year":"2023","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.aohep.2026.102189_bib0053","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/hep.27403","article-title":"The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugs","volume":"60","author":"Hellard","year":"2014","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.aohep.2026.102189_bib0054","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/s41395-018-0157-x","article-title":"Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm","volume":"113","author":"Cuadrado","year":"2018","journal-title":"Am J Gastroenterol."},{"issue":"11","key":"10.1016\/j.aohep.2026.102189_bib0055","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1111\/liv.16074","article-title":"Hepatitis C treatment outcome among people in prison: The SToP-C study","volume":"44","author":"Ryan","year":"2024","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.aohep.2026.102189_bib0056","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","article-title":"Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study","volume":"7","author":"Collaborators","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2026.102189_bib0057","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph22040509","article-title":"Cost-Effectiveness of Screening and Treating Chronic Hepatitis C Virus Infection in Zimbabwe","volume":"22","author":"Dzingirai","year":"2025","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.aohep.2026.102189_bib0058","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s44355-025-00028-w","article-title":"Closing the gap in HCV care: strategic collaboration between industry, academic, community, and nonprofit researchers","volume":"2","author":"Reau","year":"2025","journal-title":"npj Gut and Liver"},{"key":"10.1016\/j.aohep.2026.102189_bib0059","unstructured":"Association of Public Health Laboratories. Optimizing Hepatitis C Virus Testing: Reflex Guide for Laboratories. Silver Spring ed; 2023. Available from: https:\/\/www.aphl.org\/aboutAPHL\/publications\/Documents\/ID-HCV-Reflex-Guide.pdf"},{"issue":"2","key":"10.1016\/j.aohep.2026.102189_bib0060","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3350\/cmh.2024.0664","article-title":"Cost-effectiveness and return on investment of hepatitis C virus elimination in China: a modelling study","volume":"31","author":"Wu","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.aohep.2026.102189_bib0061","series-title":"Decreto N\u00b0 272\/023. Incorp\u00f3rase la determinaci\u00f3n serol\u00f3gica del virus de la hepatitis C (anti-VHC) al carn\u00e9 de salud","year":"2023"},{"issue":"4","key":"10.1016\/j.aohep.2026.102189_bib0062","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7204a1","article-title":"CDC Recommendations for Hepatitis C Testing Among Perinatally Exposed Infants and Children - United States, 2023","volume":"72","author":"Panagiotakopoulos","year":"2023","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"10.1016\/j.aohep.2026.102189_bib0063","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jhep.2019.11.012","article-title":"Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis","volume":"72","author":"Hajarizadeh","year":"2020","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.aohep.2026.102189_bib0064","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/jama.2025.10563","article-title":"Hepatitis C Screening in Emergency Departments: The DETECT Hep C Randomized Clinical Trial","volume":"334","author":"Haukoos","year":"2025","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.aohep.2026.102189_bib0065","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S2468-1253(18)30304-2","article-title":"Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis","volume":"3","author":"Hajarizadeh","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.aohep.2026.102189_bib0066","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41575-019-0177-z","article-title":"Too many people with viral hepatitis are diagnosed late - with dire consequences","volume":"16","author":"Lazarus","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"19","key":"10.1016\/j.aohep.2026.102189_bib0067","doi-asserted-by":"crossref","first-page":"421","DOI":"10.14745\/ccdr.v40i19a01","article-title":"Hepatitis C surveillance in Canada","volume":"40","author":"Payne","year":"2014","journal-title":"Can Commun Dis Rep"},{"issue":"3","key":"10.1016\/j.aohep.2026.102189_bib0068","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bjid.2019.04.010","article-title":"Hepatitis C disease burden and strategies for elimination by 2030 in Brazil. A mathematical modeling approach","volume":"23","author":"Benzaken","year":"2019","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.aohep.2026.102189_bib0069","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.vhri.2020.05.002","article-title":"Cost and Effectiveness of the Treatment of Chronic Hepatitis C in Brazil: Real-World Data","volume":"23","author":"Schwambach","year":"2020","journal-title":"Value Health Reg Issues"},{"issue":"12","key":"10.1016\/j.aohep.2026.102189_bib0070","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s00705-022-05604-6","article-title":"Prevalence of hepatitis C virus infection in patients with end-stage renal disease in Latin America and the Caribbean: a systematic review and meta-analysis","volume":"167","author":"Huarez","year":"2022","journal-title":"Arch Virol"},{"issue":"7","key":"10.1016\/j.aohep.2026.102189_bib0071","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00038-015-0708-5","article-title":"Hepatitis C in key populations in Latin America and the Caribbean: systematic review and meta-analysis","volume":"60","author":"Alonso","year":"2015","journal-title":"Int J Public Health"},{"issue":"15","key":"10.1016\/j.aohep.2026.102189_bib0072","doi-asserted-by":"crossref","first-page":"649","DOI":"10.4254\/wjh.v8.i15.649","article-title":"Hepatitis C virus infection in Argentina: Burden of chronic disease","volume":"8","author":"Ridruejo","year":"2016","journal-title":"World J Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2026.102189_bib0073","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/cld.1084","article-title":"Hepatitis C Virus Infection: What Are We Currently Doing in Latin America About WHO's Proposals for 2030?","volume":"18","author":"Roblero","year":"2021","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"7","key":"10.1016\/j.aohep.2026.102189_bib0074","doi-asserted-by":"crossref","DOI":"10.3390\/v15071413","article-title":"Abu-Freha N. Hepatitis C Elimination: Opportunities and Challenges in 2023","volume":"15","author":"Taha","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.aohep.2026.102189_bib0075","unstructured":"Minist\u00e9rio da Sa\u00fade. Guia para a Elimina\u00e7\u00e3o das Hepatites Virais no Brasil. 2025. Available from: https:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/guia_eliminacao_hepatites_virais_Brasil.pdf"},{"key":"10.1016\/j.aohep.2026.102189_bib0076","unstructured":"Coalition for Global Hepatitis Elimination. Accelerating Progress Toward Hepatitis Elimination in Latin America: Roundtable Synthesis. 2022. Available from: https:\/\/www.globalhep.org\/sites\/default\/files\/content\/webinar\/files\/2022-03\/Latin%20America%20Roundtable%20Synthesis.pdf"},{"issue":"11","key":"10.1016\/j.aohep.2026.102189_bib0077","doi-asserted-by":"crossref","first-page":"ofad517","DOI":"10.1093\/ofid\/ofad517","article-title":"Hepatitis C Treatment Uptake Following Dried Blood Spot Testing for Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot Study","volume":"10","author":"Conway","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.aohep.2026.102189_bib0078","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.eimc.2020.03.004","article-title":"Hepatitis C reflex testing in Spain in 2019: A story of success","volume":"39","author":"Crespo","year":"2021","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"issue":"8","key":"10.1016\/j.aohep.2026.102189_bib0079","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/cid\/ciad126","article-title":"Reflex Hepatitis C Virus Viral Load Testing Following an Initial Positive Hepatitis C Virus Antibody Test: A Global Systematic Review and Meta-analysis","volume":"77","author":"Tao","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.aohep.2026.102189_bib0080","unstructured":"WHO Regional Office for Europe. Screening programmes: a short guide."},{"issue":"4","key":"10.1016\/j.aohep.2026.102189_bib0081","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00030-19","article-title":"Evaluation of the Aptima HCV Quant Dx Assay Using Serum and Dried Blood Spots","volume":"57","author":"Weber","year":"2019","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.aohep.2026.102189_bib0082","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/liv.15529","article-title":"A call for the comprehensive diagnosis of viral hepatitis as a key step towards its elimination","volume":"43","author":"Crespo","year":"2023","journal-title":"Liver Int"},{"issue":"12","key":"10.1016\/j.aohep.2026.102189_bib0083","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/jvh.13374","article-title":"Pilot study using the ECHO model to enhance linkage to care for patients with hepatitis C in the custodial setting","volume":"27","author":"Mendizabal","year":"2020","journal-title":"J Viral Hepat"},{"issue":"7","key":"10.1016\/j.aohep.2026.102189_bib0084","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S2468-1253(21)00077-7","article-title":"Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study","volume":"6","author":"Hajarizadeh","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2026.102189_bib0085","doi-asserted-by":"crossref","first-page":"100643","DOI":"10.1016\/j.mayocpiqo.2025.100643","article-title":"Point-of-Care Testing and Treatment of Hepatitis C Virus in Prisons: The SINTESI Project in Sicily","volume":"9","author":"Di Marco","year":"2025","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"5","key":"10.1016\/j.aohep.2026.102189_bib0086","article-title":"Hepatitis C micro-elimination beyond prison walls: navigator-assisted test-and-treat strategy for subjects serving non-custodial sentences","volume":"11","author":"Cabezas","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.aohep.2026.102189_bib0087","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1186\/s12913-023-09849-y","article-title":"Training the healthcare workforce: the global experience with telementorship for hepatitis B and hepatitis C","volume":"23","author":"Corcorran","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.aohep.2026.102189_bib0088","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.26633\/RPSP.2020.13","article-title":"Telehealth and hepatitis C treatment for indigenous communities in the United States","volume":"44","author":"Leston","year":"2020","journal-title":"Rev Panam Salud Publica"},{"issue":"11","key":"10.1016\/j.aohep.2026.102189_bib0089","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1089\/tmj.2022.0306","article-title":"Telemonitoring of the Continuum of Care of Hepatitis C During the COVID-19 Pandemic in Brazil","volume":"29","author":"Bittencourt","year":"2023","journal-title":"Telemed J E Health"},{"issue":"10","key":"10.1016\/j.aohep.2026.102189_bib0090","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens13100859","article-title":"Advances in the elimination of viral hepatitis in mexico: a local perspective on the global initiative","volume":"13","author":"Santos-L\u00f3pez","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.aohep.2026.102189_bib0091","unstructured":"Ministerio de Salud, Gobierno de Chile. Estrategia Nacional De Salud Para Los Objetivos Sanitarios Al 2030. chrome-extension:\/\/efaidnbmnnnibpcajpcglclefindmkaj\/ https:\/\/cens.cl\/wp-content\/uploads\/2022\/03\/Estrategia-Nacional-de-Salud-al-2030.pdf?utm_source=chatgpt.com"},{"issue":"2","key":"10.1016\/j.aohep.2026.102189_bib0092","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/cld.771","article-title":"Which Strategies Should Be Implemented in Latin America to Eradicate Hepatitis C Virus by 2030?","volume":"13","author":"Ridruejo","year":"2019","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.aohep.2026.102189_bib0093","series-title":"New WHO Guidance on HCV simplified service delivery, diagnostic innovations and treatment of adolescents and children","year":"2022"},{"issue":"1","key":"10.1016\/j.aohep.2026.102189_bib0094","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1186\/s12913-024-11793-4","article-title":"Cost-effectiveness analysis of emergency department-based hepatitis C screening and linkage-to-care program","volume":"24","author":"Choi","year":"2024","journal-title":"BMC Health Serv Res"},{"issue":"11","key":"10.1016\/j.aohep.2026.102189_bib0095","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.2105\/AJPH.2024.307783","article-title":"Automated Opt-Out Hepatitis C Testing to Reduce Missed Screening Opportunities in the Emergency Department","volume":"114","author":"Sperring","year":"2024","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.aohep.2026.102189_bib0096","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12245-023-00570-5","article-title":"Emergency department contribution to HCV elimination in the Iberian Peninsula","volume":"17","author":"Buti","year":"2024","journal-title":"Int J Emerg Med"},{"key":"10.1016\/j.aohep.2026.102189_bib0097","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2023.105615","article-title":"Opt-out testing for hepatitis B and C infections in adults attending the emergency department of a large London teaching hospital","volume":"169","author":"Zeng","year":"2023","journal-title":"J Clin Virol."},{"issue":"7","key":"10.1016\/j.aohep.2026.102189_bib0098","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198520","article-title":"An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London Emergency Department","volume":"13","author":"Evans","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.aohep.2026.102189_bib0099","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/emermed-2019-208637","article-title":"Opt-out screening for HIV, hepatitis B and hepatitis C: observational study of screening acceptance, yield and treatment outcomes","volume":"37","author":"Grant","year":"2020","journal-title":"Emerg Med J"},{"issue":"8","key":"10.1016\/j.aohep.2026.102189_bib0100","doi-asserted-by":"crossref","first-page":"ofab374","DOI":"10.1093\/ofid\/ofab374","article-title":"Prevalence of Hepatitis C Virus Infection Identified From Nontargeted Screening Among Adult Visitors in an Academic Appalachian Regional Emergency Department","volume":"8","author":"Daniel Moore","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"19","key":"10.1016\/j.aohep.2026.102189_bib0101","doi-asserted-by":"crossref","first-page":"569","DOI":"10.15585\/mmwr.mm6919a1","article-title":"High prevalence of Hepatitis C infection among adult patients at four urban emergency departments - Birmingham, Oakland, Baltimore, and Boston, 2015-2017","volume":"69","author":"Galbraith","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268126000104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268126000104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:04:58Z","timestamp":1782857098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268126000104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":101,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1665268126000104"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2026.102189","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overcoming barriers to HCV screening in Latin America: From evidence to action","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2026.102189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C.","name":"copyright","label":"Copyright"}],"article-number":"102189"}}